3.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACRS Giù?
Forum
Previsione
Aclaris Therapeutics Inc Borsa (ACRS) Ultime notizie
Aclaris Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
It is Poised to be a Bull Market for Aclaris Therapeutics Inc (ACRS) - setenews.com
Can Aclaris Therapeutics Inc. stock deliver sustainable ROE2025 Key Highlights & Consistent Return Investment Signals - Newser
Why Aclaris Therapeutics Inc. (8AT) stock is a must watch tickerTrade Risk Assessment & Weekly Stock Performance Updates - Newser
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
How Aclaris Therapeutics Inc. (8AT) stock correlates with oil markets2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Can Comfort Intech Limited Maintain Profitability in a Rising Rate EnvironmentCandlestick Trading Patterns & Free Dynamic Profit Opportunities - earlytimes.in
Is Aclaris Therapeutics Inc. stock attractive for income investors2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Aclaris Therapeutics (ACRS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Aclaris Therapeutics engages investors at Piper Sandler Conference - Traders Union
Aclaris Therapeutics Inc (ACRS) is looking forward to a strong quarter - Setenews
Why Aclaris Therapeutics Inc. stock could rally in 2025Trade Analysis Report & Long-Term Capital Growth Ideas - BỘ NỘI VỤ
Can Aclaris Therapeutics Inc. stock beat analyst upgrades - moha.gov.vn
Check out Aclaris Therapeutics's stock price (ACRS) in real time - CNBC
Aclaris Therapeutics, Inc.Common Stock (NQ: ACRS - Markets Financial Content
Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Top investors say Aclaris Therapeutics Inc (ACRS) ticks everything they need - setenews.com
Why Aclaris Therapeutics Inc. (8AT) stock attracts HNW investors - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock bottoming after sell offMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical Trial - MSN
Discovering Aclaris Therapeutics And Two Other Noteworthy Penny Stocks - Yahoo Finance
How Aclaris Therapeutics Inc. stock benefits from tech adoptionNew Guidance & Smart Money Movement Alerts - newser.com
What hedge fund moves indicate for Aclaris Therapeutics Inc. (8AT) stockTrade Signal Summary & Daily Momentum Trading Reports - newser.com
Is Aclaris Therapeutics Inc. stock a contrarian buyPortfolio Performance Report & Entry Point Confirmation Signals - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock benefit from mergers2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock a buy for dividend portfoliosLayoff News & Fast Momentum Entry Tips - newser.com
How cyclical is Aclaris Therapeutics Inc. (8AT) stock compared to rivalsPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Can Aclaris Therapeutics Inc. stock deliver strong Q4 earnings2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What high frequency data says about Aclaris Therapeutics Inc.2025 Market Outlook & Safe Entry Momentum Stock Tips - newser.com
Rheumatoid Arthritis Market to Grow Significantly from ~20 Billion Over the Next Decade by 2034, DelveInsight Observes | R-Pharm, Taisho Pharmaceuticals, GSK, Aclaris, BMS, Eli Lilly, Taiho - Barchart.com
Aclaris Therapeutics at Jefferies Conference: Strategic Expansion in Biopharma By Investing.com - Investing.com Canada
Will Aclaris Therapeutics Inc. stock deliver shareholder value2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):